Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.

Wu JH, Liang XA, Wu YM, Li FS, Dai YM.

Oncol Rep. 2013 Jan;29(1):125-32. doi: 10.3892/or.2012.2077. Epub 2012 Oct 9.

PMID:
23064448
2.

Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.

Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH, Ding DC, Chu TY.

Int J Gynecol Cancer. 2010 May;20(4):513-9. doi: 10.1111/IGC.0b013e3181c7fe6e.

PMID:
20442585
3.

Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings.

Yang N, Eijsink JJ, Lendvai A, Volders HH, Klip H, Buikema HJ, van Hemel BM, Schuuring E, van der Zee AG, Wisman GB.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3000-7. doi: 10.1158/1055-9965.EPI-09-0405. Epub 2009 Oct 20.

4.
5.

Identification of novel DNA methylation markers in cervical cancer.

Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan MW, Chu TY, Sun CA, Chang CC, Yu MH.

Int J Cancer. 2008 Jul 1;123(1):161-7. doi: 10.1002/ijc.23519.

6.

Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.

Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C.

Gynecol Oncol. 2010 Jan;116(1):99-104. doi: 10.1016/j.ygyno.2009.09.032.

PMID:
19836067
7.

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.

Boers A, Wang R, van Leeuwen RW, Klip HG, de Bock GH, Hollema H, van Criekinge W, de Meyer T, Denil S, van der Zee AGJ, Schuuring E, Wisman GBA.

Clin Epigenetics. 2016 Mar 9;8:29. doi: 10.1186/s13148-016-0196-3. eCollection 2016.

8.

PAX1 methylation as a potential biomarker for cervical cancer screening.

Kan YY, Liou YL, Wang HJ, Chen CY, Sung LC, Chang CF, Liao CI.

Int J Gynecol Cancer. 2014 Jun;24(5):928-34. doi: 10.1097/IGC.0000000000000155.

PMID:
24844223
9.
10.

Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.

Lendvai Á, Johannes F, Grimm C, Eijsink JJ, Wardenaar R, Volders HH, Klip HG, Hollema H, Jansen RC, Schuuring E, Wisman GB, van der Zee AG.

Epigenetics. 2012 Nov;7(11):1268-78. doi: 10.4161/epi.22301. Epub 2012 Sep 27.

11.

Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.

Lim EH, Ng SL, Li JL, Chang AR, Ng J, Ilancheran A, Low J, Quek SC, Tay EH.

Gynecol Oncol. 2010 Nov;119(2):225-31. doi: 10.1016/j.ygyno.2010.07.028. Epub 2010 Aug 13.

PMID:
20708786
12.

Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer.

Farkas SA, Milutin-Gašperov N, Grce M, Nilsson TK.

Epigenetics. 2013 Nov;8(11):1213-25. doi: 10.4161/epi.26346. Epub 2013 Sep 12.

PMID:
24030264
13.

DNA methylation analysis in liquid-based cytology for cervical cancer screening.

Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G, Widschwendter M.

Int J Cancer. 2009 Dec 15;125(12):2995-3002. doi: 10.1002/ijc.24745.

14.

Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse.

Lai HC, Lin YW, Huang RL, Chung MT, Wang HC, Liao YP, Su PH, Liu YL, Yu MH.

Cancer. 2010 Sep 15;116(18):4266-74. doi: 10.1002/cncr.25252.

15.

Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.

Chang CC, Huang RL, Liao YP, Su PH, Hsu YW, Wang HC, Tien CY, Yu MH, Lin YW, Lai HC.

BMC Cancer. 2015 May 19;15:418. doi: 10.1186/s12885-015-1411-x.

16.

[Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application].

Zhong ZJ, Yang JX, Cao DY, Sun Y, Sun LL, Cheng XM, Chen J, Lang JH, Shen K.

Zhonghua Fu Chan Ke Za Zhi. 2012 Mar;47(3):196-200. Chinese.

PMID:
22781071
17.

Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis.

Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, Lieber A, Kiviat N.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):114-23.

18.

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.

Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ.

J Natl Cancer Inst. 2004 Feb 18;96(4):294-305.

PMID:
14970278
19.
20.

Supplemental Content

Support Center